Antifibrotic drugs as treatment of nonidiopathic pulmonary fibrosis interstitial pneumonias: the time is now (?)
Sign Up to like & getrecommendations! Published in 2017 at "Current Opinion in Pulmonary Medicine"
DOI: 10.1097/mcp.0000000000000408
Abstract: Purpose of review Therapeutic advances in the management of idiopathic pulmonary fibrosis (IPF) has led to improved outcomes with the use of the antifibrotic agents pirfenidone and nintedanib, with a number of randomized studies demonstrating… read more here.
Keywords: treatment; antifibrotic drugs; pulmonary fibrosis; ipf ... See more keywords
Evaluation of the potential complication of interstitial lung disease associated with antifibrotic drugs using data from databases reporting spontaneous adverse effects
Sign Up to like & getrecommendations! Published in 2022 at "Clinical and Translational Science"
DOI: 10.1111/cts.13419
Abstract: Interstitial lung disease (ILD), as an adverse effect of certain drugs, leads to inflammation and damage in the walls of the alveoli, making it difficult for the alveoli to take up oxygen. Interstitial pneumonia with… read more here.
Keywords: interstitial lung; spontaneous adverse; using data; lung disease ... See more keywords